Companies: 10,795·Total market cap: $144.5T
Whitehawk Therapeutics Inc

Whitehawk Therapeutics Inc

WHWKNASDAQHealthcare● Active
$4.02
$-0.13(-3.13%)
Market Cap$198798901
P/E Ratio—
52W High$5.495
52W Low$1.57
SEC Filings

Whitehawk Therapeutics Inc (WHWK) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001422142 · WHWK · NASDAQ · as of Jun 9, 2026

Filing snapshot

642
Total Filings
S-3
Latest Form
2026-05-29
Most Recent
2017
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001422142 · Updated hourly · Not investment advice

Latest Annual Report

10-K · Annual ReportFY
Filed Date
2026-03-12
Fiscal Year End
Mar 12, 2026
Accession No.
0001193125-26-104158
Primary Document
whwk-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001422142 · Accession 0001193125-26-104158

Latest Key Filings

10-QQuarterly Report
10-Q
2026-05-07
View 10-Q on SEC
8-KCurrent Report
8-K
2026-05-21Material Event
View 8-K on SEC
Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
S-3Shelf Registration
S-3
2026-05-29
View
8-KCurrent Report
8-K
2026-05-21
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-18
View
SCHEDULE 13D/ASCHEDULE 13D/A
SCHEDULE 13D/A
2026-05-14
View
8-KCurrent Report
8-K
2026-05-13
View
10-QQuarterly Report
10-Q
2026-05-07
View
8-KCurrent Report
8-K
2026-05-07
View
DEFA14AProxy Statement (Additional)
DEFA14A
2026-04-28
View
ARSARS
ARS
2026-04-28
View
DEF 14AProxy Statement
DEF 14A
2026-04-28
View
S-8Employee Stock Plan Registration
S-8
2026-03-12
View
10-KAnnual Report
10-K
2026-03-12
View
8-KCurrent Report
8-K
2026-03-12
View
3Initial Statement of Beneficial Ownership
Initial Statement of Beneficial Ownership
2025-12-02
View
10-QQuarterly Report
10-Q
2025-11-06
View
Showing 1–15 of 423 filingsForm 4 / 144 hidden· 642 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001422142  |  Exchange: NASDAQ · Healthcare

Whitehawk Therapeutics Inc (NASDAQ: WHWK) has submitted 642 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2017. As a Healthcare sector company with CIK 0001422142, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Whitehawk Therapeutics Inc's most comprehensive regulatory disclosure. The most recent Whitehawk Therapeutics Inc 10-K was filed on 2026-03-12 for fiscal year ending 2026. Historical WHWK 10-K annual reports are available from 2008 through 2026.

Investors researching Whitehawk Therapeutics Inc SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09
Related Companies SEC Filings — Healthcare
IMMX SEC Filings →OVID SEC Filings →ZNTL SEC Filings →MGNX SEC Filings →CNTX SEC Filings →ONCY SEC Filings →PLRX SEC Filings →CLNN SEC Filings →
→ WHWK Financials→ WHWK Earnings→ WHWK Insider Trades

Frequently Asked Questions

WHWK SEC Filings · 8 questions

Whitehawk Therapeutics Inc (WHWK) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 642 filings and access original documents at no cost. Whitehawk Therapeutics Inc's CIK is 0001422142.

WHWK SEC filingsWhitehawk Therapeutics Inc SEC documentsfind WHWK 10-K